Lilia Lima

Anvisa (the Brazilian Health Regulatory Agency⚕) approved a new regulation for the registration of biosimilar medicines during the Collegiate Board meeting held on Monday, May 27th For a market like Brazil with a high patient population, Biosimilars are seen as a crucial strategy for public health due to their potential to reduce medicine costs and increase accessibility to new biological products and technologies, all while maintaining safety and efficacy The impact of this new regulation on access to biosimilars in Brazil is expected to be significant. By simplifying the development and registration process, the regulation aims to reduce the time and cost associated with bringing biosimilar medicines to market. This can lead to lower costs for these medicines, making them more accessible to patients. Additionally, by allowing the use of international reference medicines in certain situations, the regulation addresses potential issues of local unavailability, further ensuring that patients have better access to necessary biological treatments. Overall, this regulatory update is anticipated to enhance the availability and affordability of biosimilars in Brazil, thereby benefiting public health. Source: https://lnkd.in/gMwPV7Vm #BiosimilarsBrazil #ANVISA #MarketAccess #Biosimilars #HealthcareAccess #AffordableMedicine #BiosimilarRegulation #HealthInnovation #PatientAccess #HealthPolicy #DrugRegulation #PharmaBrazil

34

The power to think globally and act locally! How a global strategy and project can be activated locally in different ways to move the needle for patients in different healthcare systems. Also, but definately not less important, patients leading a multistakeholder discussion to raise their voices about their unmet needs and being able to “co-create” solutions or next steps with health authorities. #globalhearthub #institutoladoalado #patientledresearch #patientengagement #advocacy #multistakeholderdiscussion

21

5 comentários

CARDIOVASCULAR. Cardiovascular risk factors and vascularcomplications in adults with early- and late-onset diabetes. Dr. David. #director #gerente #industriafarmaceutica #farma #bigpharma #pharma #cardiovascular #diabetes #cardiologia

5

1 comentário

⚡️ SKIN & DIGITAL SUMMIT 2024 ⚡️ The sixth Skin & Digital Summit (SDS) of 2024 is approaching, and we continue to shape the 'Skin & Digital' narrative. The next SDS, hosted by IMCAS Americas, is scheduled for Saturday, April 27, 2024, in Sao Paulo, Brazil and will be held on-site only. 🇧🇷 Digital Tech in Dermatology & Beauty: Data is Shaping the Future 🇧🇷 ▶️ Augmented reality leading the way in aesthetic medicine ▶️ Transforming Dermatology – generative AI, and the power of data ▶️ How AI is revolutionizing aspects of plastic surgery ▶️ Photoprotection - UV filters are the vehicle…but data is the fuel! ▶️ Conclusion & next steps https://lnkd.in/eADKeTFW I extend my deepest thanks to all our speakers and moderators. Their invaluable contributions are instrumental in shaping that conversation Jane Yoo, Sergio TALARICO, Alessandra Haddad, Geisa Costa, DIALA HAYKAL���‍⚕️🔵, and Gustavo Filippo, MD. I am profoundly grateful for their dedication and insights. ▶️ Thanks to our scientific partners in 2024: Advancing Innovation in Dermatology, Inc., IMCAS , IFPA, GlobalSkin - International Alliance of Dermatology Patient Organizations, the Master of Aesthetics, and Magic Wand Initiative. #data #skin #dermatology #aesthetics #aestheticmedicine #plasticsurgery #skincare #digital #artificialintelligence #ai #generativeai #genai #machinelearning #ml #impact #access #digitaldivide #misinformation #socialmedia #vr #ar #innovation #data #photoprotection #skindigitalsummit

24

How many times have you received an idea and your first reaction was to reject it? What led you to do that? Why didn't you give it a chance? Years ago, when I was the General Manager of Novo Nordisk Brazil, we formed a leadership group to develop innovative projects. We ended up discarding many of the ideas presented, perhaps because they were not applicable to our reality at that time or due to a lack of curiosity in exploring them further. Today, with the WeLatam mindset of LOVE THE IDEA FOR FIVE MINUTES, I am pleased to see that each perspective is being better evaluated before being discarded too soon. With this culture: 1. We respect and value people's creativity. 2. We practice curiosity instead of making quick judgments.  3. ⁠We ask questions to better understand the context, avoiding forming hasty opinions. 4. We recognize the potential of an idea, even if it seems unfeasible at first. LOVE THE IDEA FOR FIVE MINUTES is what drives innovation. Therefore, my advice is: the next time an idea arises, be open and give it the space it deserves!

216

13 comentários

Allergy symptoms are caused by your immune system mistaking harmless substances as threats and going into defense mode, these substances are called allergens. While cold is when a cold virus makes its way into your respiratory tract and your immune system attacks. Discover 10 essential similarities and differences that can guide you in distinguishing between a cold and allergies. And for each symptom Bayer has a solution! ;)

8

From McKinsey Insights: Healthcare in Latin America: What are consumers looking for? https://lnkd.in/dDBg6kSp A very interesting analysis about Healthcare in Latin America. We see that we have space for virtual access to healthcare and for apps that can help consumers to take care of their health, as the costs are high and access to healthcare insurances and to medical assitance is still a major issue.

12

The Brazilian health sector is projected to grow around 10% in each of the next two years! Find out how to navigate this huge opportunity by reading our new article Brazilian Pharmaceutical Market: business potential and prospects for 2025, produced by Dr. Fisiologia. This comprehensive guide takes a deep dive into the pharmaceutical industry, public health, health plans and health technology. Discover: Market potential and growth forecasts Key challenges and opportunities Overview of public and private healthcare Data-driven strategies for success Don't miss this opportunity! Download now by clicking the link below or point your camera to the qr code on the image. https://lnkd.in/dNDzBW8F #Brazil #Pharmaceutical #Health #Marketresearch

10

It’s a marathon, not a sprint Starting this 2Q, I had the chance to reflect on the months that just went by, from which I take with me 3 learnings as a leader 1. Giving ontime and direct feedback with clear an concise communication, more than a responsability, is a GIFT to your colaborators. Creating a culture resilient towards feedback is a must, reminding them not take things personally and understanding that different team members respond different to feedback. It definetely requires you to be conscious, cautious and assertive when giving it. 2. It’s a marathon, not a sprint. We need to learn how to develop “EXECUTIVE STAMINA” for ourselves in order to permeate it towards the whole team. And just as any other race, it requieres you to push when there is a high hill up front, positive self talk and measured breathing to stop and go when needed 3. And last but not least: Gratitude. I am absolutely grateful to see that I work with caring human beings that take the time to ask their own leader genuinely “ How are you boss? Count with me, we are gonna make this happen”! And so, after taking a look back, we prepare ourselves for this new quarter and we say again On your marks, get set and go!

68

2 comentários

🌍✨ Today marks World Asthma Day 2024! ✨🌍 On this day, let's celebrate the remarkable resilience of individuals living with asthma. They defy the constraints of their condition, surpassing limits, and embracing life to the fullest. At Chiesi we are honored to share compelling stories of patients who have defied the limitations imposed by their condition. Today, we shine a spotlight on their inspirational journeys, highlighting their resilience and determination in overcoming the challenges of living with asthma. Behind these inspiring individuals lie stark statistics: Asthma is one of the most common chronic non-communicable diseases that affects over 260 million worldwide, leading to 450,000 annual deaths, many of which could have been prevented. Join us in honoring our patients and raising awareness about this respiratory disease. Happy World Asthma Day! 🌍 #Limitless #Sustainability #RespiratoryHealth

34

ClinRegs has posted an update to the Brazil profile. "Law No. 14,874, of May 28, 2024 was published in the Official Diary of the Union on May 29, 2024, and comes into force on August 27, 2024. The new law provides principles, guidelines, and rules for conducting research with human beings by public or private institutions and establishes the National System of Ethics in Research with Human Beings. "The ClinRegs team will incorporate the law into the Brazil profile once it is in force." #NIAID #ClinRegs #Brazil #ANVISA https://lnkd.in/dfRKjrQ

2

· Latin America will be the world's fastest growing region for pharmaceuticals up to 2027, with a stunning expected compound annual growth rate of 22 percent, according to recent reporting from IQVIA. · The Indian subcontinent can also expect sizeable growth over the next three years , Pharmerging 7.1 percent, middle east 6.6 percent , although the US, Europe, and East Asia will remain the largest pharma markets globally

23

Patients rely on complex generics for many indications, including chronic conditions such as asthma, schizophrenia and osteoporosis. For patients that require monthly drug supplies, the availability of generics may make the difference between being able to afford or stopping treatment. 👉 Find out what Teva is doing to help improve access to these vital medicines, supporting patients to achieve a better quality of life: https://lnkd.in/gtST346J #GenericMedicines #ComplexGenerics

5

To all my Life Science connections: Exciting 'stuff' coming up the rest of the year if you are interested in Market access, Marketing Compliance, Business innovation and Private - Public Partnerships, Pathology & Pharmacology and Medical Affairs 🚀 See our span of courses and professional networks below

8

Throughout May, our focus has been on educating patients about Asthma . Below are some of the key highlights from our educational series and link to all the videos shared throughout this month! #respirangers #breathefree@Cipla #WAD@Cipla #Caringforlife #CiplaSSA

6

Proud to share my achievement in the certificate course in clinical research offered by Udemy !This certificate represents a milestone in my journey towards advancing healthcare through research. Special thanks to Chitkara University for encouraging us with the slogan of "Explore your potential" .Grateful for the opportunity to expand my knowledge and excited for what’s next. #ClinicalResearch #Healthcare #ProfessionalGrowth”

10

Meeting the needs of our patients is the most rewarding responsibility for our region. But often, it’s also our greatest challenge. A recent McKinsey article showed that in Latin America, #healthcare remains inaccessible for far too many. According to the article, 62% of people reported deferring medical care due to cost and accessibility in the past year. This includes critical health services like vaccinations, blood tests and imaging, which play a significant role in our ability to prevent and treat chronic diseases like #cardiovasculardisease and #cancer – two growing epidemics that disproportionately impact low and middle-income communities.    Creating more sustainable and accessible care is critical to reversing the course and providing some relief to already strained healthcare systems. In LACan, we’re driving change by devising access routes that are as innovative as our medicines, supporting more patient-centric healthcare delivery models that understand and accommodate patients in our countries. Building a healthcare legacy for the future requires collective commitment. Through collaboration and public-private partnerships across LACan, we are working with civil society, policymakers, patient organizations, healthcare stakeholders and partners inside and outside the pharmaceutical industry to support synergistic strategies that help more people overcome the complex barriers they face for the care they need. The challenge is to continue pushing boundaries to shape health systems that can achieve better outcomes for patients and growth for our societies. https://mck.co/4alrw27

119

3 comentários